Prognosis
France, an Early Critic of AstraZeneca’s Vaccine, Has Changed Its Mind
- Shot made by Anglo-Swedish drug maker deemed fit for over 55
- Latest flip-flop comes as Paris enters yet another lockdown
This article is for subscribers only.
France, one of the earliest critics of the AstraZeneca Plc vaccine, has done an almost 180-degree turn from saying it was not fit for the elderly to clearing it for the middle-aged and beyond.
The reversal became official in a Friday tweet, via Health Minister Olivier Veran: “The High Health Authority (HAS) gives its green light to the resumption of vaccination with AstraZeneca for people age 55 and over.”